Literature DB >> 33578749

Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.

Akylbek Sydykov1,2, Argen Mamazhakypov1, Abdirashit Maripov2,3, Djuro Kosanovic4, Norbert Weissmann1, Hossein Ardeschir Ghofrani1, Akpay Sh Sarybaev2,3, Ralph Theo Schermuly1.   

Abstract

Alveolar hypoxia is the most prominent feature of high altitude environment with well-known consequences for the cardio-pulmonary system, including development of pulmonary hypertension. Pulmonary hypertension due to an exaggerated hypoxic pulmonary vasoconstriction contributes to high altitude pulmonary edema (HAPE), a life-threatening disorder, occurring at high altitudes in non-acclimatized healthy individuals. Despite a strong physiologic rationale for using vasodilators for prevention and treatment of HAPE, no systematic studies of their efficacy have been conducted to date. Calcium-channel blockers are currently recommended for drug prophylaxis in high-risk individuals with a clear history of recurrent HAPE based on the extensive clinical experience with nifedipine in HAPE prevention in susceptible individuals. Chronic exposure to hypoxia induces pulmonary vascular remodeling and development of pulmonary hypertension, which places an increased pressure load on the right ventricle leading to right heart failure. Further, pulmonary hypertension along with excessive erythrocytosis may complicate chronic mountain sickness, another high altitude maladaptation disorder. Importantly, other causes than hypoxia may potentially underlie and/or contribute to pulmonary hypertension at high altitude, such as chronic heart and lung diseases, thrombotic or embolic diseases. Extensive clinical experience with drugs in patients with pulmonary arterial hypertension suggests their potential for treatment of high altitude pulmonary hypertension. Small studies have demonstrated their efficacy in reducing pulmonary artery pressure in high altitude residents. However, no drugs have been approved to date for the therapy of chronic high altitude pulmonary hypertension. This work provides a literature review on the role of pulmonary hypertension in the pathogenesis of acute and chronic high altitude maladaptation disorders and summarizes current knowledge regarding potential treatment options.

Entities:  

Keywords:  chronic mountain sickness; high altitude; high altitude pulmonary edema; hypoxic pulmonary vasoconstriction; pulmonary hypertension

Year:  2021        PMID: 33578749      PMCID: PMC7916528          DOI: 10.3390/ijerph18041692

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  363 in total

1.  Adult subacute mountain sickness--a syndrome at extremes of high altitude.

Authors:  R G Poduval
Journal:  J Assoc Physicians India       Date:  2000-05

2.  Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.

Authors:  Tetsutaro Nagaoka; Yoshiteru Morio; Nina Casanova; Natalie Bauer; Sarah Gebb; Ivan McMurtry; Masahiko Oka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-05       Impact factor: 5.464

3.  THE HEART AND PULMONARY CIRCULATION IN CHILDREN AT HIGH ALTITUDES: PHYSIOLOGICAL, ANATOMICAL, AND CLINICAL OBSERVATIONS.

Authors:  D PENALOZA; J ARIAS-STELLA; F SIME; S RECAVARREN; E MARTICORENA
Journal:  Pediatrics       Date:  1964-10       Impact factor: 7.124

4.  Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update.

Authors:  Andrew M Luks; Scott E McIntosh; Colin K Grissom; Paul S Auerbach; George W Rodway; Robert B Schoene; Ken Zafren; Peter H Hackett
Journal:  Wilderness Environ Med       Date:  2014-12       Impact factor: 1.518

5.  Effect of hypoxia on regional lung perfusion, by scanning.

Authors:  R Viswanathan; S Subramanian; T G Radha
Journal:  Respiration       Date:  1979       Impact factor: 3.580

6.  High-altitude pulmonary edema is initially caused by an increase in capillary pressure.

Authors:  M Maggiorini; C Mélot; S Pierre; F Pfeiffer; I Greve; C Sartori; M Lepori; M Hauser; U Scherrer; R Naeije
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

7.  Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.

Authors:  Joseph T Crossno; Chrystelle V Garat; Jane E B Reusch; Kenneth G Morris; Edward C Dempsey; Ivan F McMurtry; Kurt R Stenmark; Dwight J Klemm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-22       Impact factor: 5.464

Review 8.  Pulmonary hypertension in high-altitude dwellers: novel mechanisms, unsuspected predisposing factors.

Authors:  Urs Scherrer; Pierre Turini; Sébastien Thalmann; Damian Hutter; Carlos Salinas Salmon; Thomas Stuber; Sidney Shaw; Pierre-Yves Jayet; Céline Sartori-Cucchial; Mercedes Villena; Yves Allemann; Claudio Sartori
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

9.  Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m).

Authors:  Barbara E Jones; Suzy Stokes; Suzi McKenzie; Eric Nilles; Gregory J Stoddard
Journal:  Wilderness Environ Med       Date:  2012-10-10       Impact factor: 1.518

10.  Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.

Authors:  Virginia Chamorro; Daniel Morales-Cano; Javier Milara; Bianca Barreira; Laura Moreno; María Callejo; Gema Mondejar-Parreño; Sergio Esquivel-Ruiz; Julio Cortijo; Ángel Cogolludo; Joan A Barberá; Francisco Perez-Vizcaino
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

View more
  10 in total

1.  Heterozygous Tropomodulin 3 mice have improved lung vascularization after chronic hypoxia.

Authors:  Tsering Stobdan; Pritesh P Jain; Mingmei Xiong; Vineet Bafna; Jason X-J Yuan; Gabriel G Haddad
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 6.150

Review 2.  A century of exercise physiology: lung fluid balance during and following exercise.

Authors:  Giuseppe Miserocchi; Egidio Beretta
Journal:  Eur J Appl Physiol       Date:  2022-10-20       Impact factor: 3.346

3.  An Exaggerated Rise in Pulmonary Artery Pressure in a High-Altitude Dweller during the Cold Season.

Authors:  Akylbek Sydykov; Abdirashit Maripov; Nadira Kushubakova; Kubatbek Muratali Uulu; Samatbek Satybaldyev; Cholpon Kulchoroeva; Djuro Kosanovic; Akpay Sarybaev
Journal:  Int J Environ Res Public Health       Date:  2021-04-10       Impact factor: 3.390

4.  Right Ventricular Response to Acute Hypoxia Exposure: A Systematic Review.

Authors:  Argen Mamazhakypov; Meerim Sartmyrzaeva; Nadira Kushubakova; Melis Duishobaev; Abdirashit Maripov; Akylbek Sydykov; Akpay Sarybaev
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

Review 5.  Oxidative Stress and Diseases Associated with High-Altitude Exposure.

Authors:  Eduardo Pena; Samia El Alam; Patricia Siques; Julio Brito
Journal:  Antioxidants (Basel)       Date:  2022-01-28

6.  Biomechanical and structural responses of the aorta to intermittent hypobaric hypoxia in a rat model.

Authors:  Andrés Utrera; Álvaro Navarrete; Alejandro González-Candia; Claudio García-Herrera; Emilio A Herrera
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

Review 7.  A Study on the Molecular Mechanism of High Altitude Heart Disease in Children.

Authors:  Qu-Zhen Tashi; Sang-Bu Tsering; Na-Ni Zhou; Yi Zhang; Yu-Juan Huang; Jia Jia; Ting-Jun Li
Journal:  Pharmgenomics Pers Med       Date:  2022-07-21

8.  Inflammatory gene expression during acute high-altitude exposure.

Authors:  Kathy Pham; Shyleen Frost; Keval Parikh; Nikhil Puvvula; Britney Oeung; Erica C Heinrich
Journal:  J Physiol       Date:  2022-08-17       Impact factor: 6.228

9.  Alternative splicing signature of alveolar type II epithelial cells of Tibetan pigs under hypoxia-induced.

Authors:  Haonan Yuan; Xuanbo Liu; Zhengwen Wang; Yue Ren; Yongqing Li; Caixia Gao; Ting Jiao; Yuan Cai; Yanan Yang; Shengguo Zhao
Journal:  Front Vet Sci       Date:  2022-09-16

Review 10.  High Altitude Pregnancies and Vascular Dysfunction: Observations From Latin American Studies.

Authors:  Alejandro Gonzalez-Candia; Emilio A Herrera
Journal:  Front Physiol       Date:  2021-12-07       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.